Filing Details
- Accession Number:
- 0001209191-12-005096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-01-24 14:52:09
- Reporting Period:
- 2012-01-23
- Filing Date:
- 2012-01-24
- Accepted Time:
- 2012-01-24 14:52:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1107332 | Dendreon Corp | DNDN | Pharmaceutical Preparations (2834) | 223203193 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1420482 | W Mark Frohlich | 1301 2Nd Ave Suite 3200 Seattle WA 98101 | See General Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-01-23 | 3,230 | $13.24 | 328,312 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.